Target intelligence / Profile preview

Novel transcript, antisense to SHANK2 (ENSG00000286708)

Target
ENSG00000286708
Molecular classification
Other, Natural antisense transcript, Noncoding RNA
01

Overview

This entry refers to a putative, uncharacterized noncoding RNA (natural antisense transcript) arising from the SHANK2 locus. Natural antisense transcripts (NATs) are a class of RNAs transcribed from the opposite strand of a protein-coding or noncoding gene; they often regulate their sense counterpart’s expression through transcriptional interference, RNA masking, chromatin remodeling, or double-stranded RNA mechanisms. The specific transcript “novel transcript, antisense to SHANK2” does not have any established function or role as a molecular target and is not classified as a receptor, enzyme, or other commonly targeted protein. Its presence in the genome annotation indicates it may play a regulatory role in modulating SHANK2 gene expression, which itself is involved in synaptic function and is implicated in neurodevelopmental disorders such as autism spectrum disorder; however, no direct functional or disease role for this antisense transcript has been established.

Other names
novel transcript, antisense to SHANK2
02

Mechanism of action

Not applicable (no drugs known to target this transcript)

03

Biological functions

Regulation of gene expressionTranscriptional interferenceEpigenetic regulation
04

Disease associations

Autism spectrum disorderNeurodevelopmental disorders

Beyond the preview

Go deeper on Novel transcript, antisense to SHANK2 (ENSG00000286708).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to SHANK2 (ENSG00000286708).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call